Science Current Events | Science News | Brightsurf.com
 

Cell skeleton may hold key to overcoming drug resistance in cancer

October 04, 2007

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Research Australia


Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles


Non-integrating viral vector delivers chemotherapy-sensitizing gene to pancreatic cancer cells
New Rochelle, NY, February 26, 2016--A novel HIV-based lentiviral vector can introduce a gene to pancreatic tumor cells that makes them more sensitive to the chemotherapeutic drug gemcitabine, without integrating into cellular DNA.

Scientists pioneer 3-D-printed drug delivering micro-needles
Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery.

Innovative light therapy reaches deep tumors
Light long has been used to treat cancer. But phototherapy is only effective where light easily can reach, limiting its use to cancers of the skin and in areas accessible with an endoscope, such as the gastrointestinal tract.

CNIO associates rare gene variants with side effects from chemotherapy with paclitaxel
Paclitaxel is a chemotherapeutic drug that has been shown to be highly effective when treating solid tumours, such as breast, ovarian and lung tumours.

Major discovery on the mechanism of drug resistance in leukemia and other cancers
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) and her collaborators.

Genetic aberration paves the way for new treatment of cancer disease
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients.

Nanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.

CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles

Physicians' Cancer Chemotherapy Drug Manual 2016

Physicians' Cancer Chemotherapy Drug Manual 2016
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2016, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like belinostat, blinatumomab, lenvatinib, nivolumab, olaparib, palbociclib, panobinostat, pembrolizumab, and ramucirumab • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams...

Drugs Targeting B-Cells in Autoimmune Diseases (Milestones in Drug Therapy)

Drugs Targeting B-Cells in Autoimmune Diseases (Milestones in Drug Therapy)
by Xavier Bosch (Editor), Manuel Ramos-Casals (Editor), Munther A Khamashta (Editor)


This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with...

Physicians' Cancer Chemotherapy Drug Manual 2015

Physicians' Cancer Chemotherapy Drug Manual 2015
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2015, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab. • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of...

Basic and Clinical Pharmacology 13 E

Basic and Clinical Pharmacology 13 E
by Bertram Katzung (Author), Anthony Trevor (Author)


Gain a full understanding of the basic science and clinical use of drugs with the most up-to-date and comprehensive pharmacology text in the health sciences400 ILLUSTRATIONS--MANY IN FULL COLORA Doody's Core Title for 2015!Coverage that spans every aspect of medical pharmacology: Encompasses every aspect of medical pharmacology including botanicals and over-the-counter drugs New chapter on pharmacogenomics with important examples Emphasis is placed on discussion of drug groups and prototypes Clinically relevant, the book includes sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects Full-color presentation with more than 400 illustrations Case studies introduce clinical problems in most chapters Summary tables and diagrams...

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
by Lawrence Panasci (Editor), Raquel Aloyz (Editor), Moulay Alaoui-Jamali (Editor)


​A comprehensive review of the recent developments in DNA repair research that have potential for translational applications. The book explains in detail the various biological mechanisms by which cancer cells can circumvent anticancer therapy and limits its usefulness in patients. They also review the impact of such novel inhibitors of DNA repair mechanisms as methylguanine-DNA-methyltransferase. Also examined are inhibitors of other DNA repair enzymes such as PARP and DNA-PK. The book captures-for both cancer researchers and oncologists dealing with hallmark "relapse" or "drug resistance" phenomena on a daily basis-the many exciting new uses of DNA repair inhibitors, either alone or in combination with anticancer therapies.​

Drug Delivery in Oncology: From Basic Research to Cancer Therapy, 3 Volume Set

Drug Delivery in Oncology: From Basic Research to Cancer Therapy, 3 Volume Set
by Felix Kratz (Editor), Peter Senter (Editor), Henning Steinhagen (Editor)


In this first authoritative overview on modern cancer chemotherapy 121 international specialists have contributed their experience and recent data for what is likely to become the gold standard in the field.

The authors summarize knowledge gained over the past decade, from basic concepts to successful applications in the clinic, covering active and passive targeting strategies as well as tissue-specific approaches. All current and future targeted delivery systems are discussed, from ligand-based to antibody-based polymer-based systems, right up to micro- and nanoparticulate systems. A special section covers the delivery of nucleic acid therapeutics, such as siRNA, miRNA and antisense nucleotides. In each case, a description of the basic technique is followed by a discussion of...

Psychopharmacology: Drugs, the Brain and Behavior

Psychopharmacology: Drugs, the Brain and Behavior
by Jerrold S. Meyer (Author), Linda F. Quenzer (Author)


Recent advances in molecular pharmacology and brain imaging have revolutionized our understanding of how psychoactive drugs work. Now, from the authors of Principles of Neuropsychopharmacology, comes a new undergraduate textbook integrating these developments. The first section of the book provides extensive foundation materials, including the basic principles of pharmacology, neurophysiology and neuroanatomy, synaptic transmission, and methods in psychopharmacology. The second section describes key features of major neurotransmitter systems, including the catecholamines, serotonin, acetylcholine, glutamate and GABA. The third and fourth sections discuss theories and mechanisms of drug addiction and psychopathology. All major substances of abuse as well as drugs used to treat mental...

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)
by Benjamin Bonavida (Editor)


This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.

Litt's Drug Eruption and Reaction Manual, 21st Edition

Litt's Drug Eruption and Reaction Manual, 21st Edition
by Jerome Z. Litt (Author)


Internationally relied upon by medical practitioners for its unparalleled focus on adverse effects and cutaneous reactions, Litt’s Drug Eruption & Reaction Manual is a succinct clinical reference and essential drug-safety tool for patient care. The new edition has been comprehensively revised and updated, featuring an enlarged section of tables for class reactions and new entries for recently licensed drugs. It has been comprehensively revised and updated throughout to act as a quick reference, and each entry includes: Summaries of numbers of reports and incidence for reactions Clinically important and potentially hazardous drug–drug interactions Categories of adverse drug reactions, eruptions, and cutaneous reaction patterns Essential reference information on prescription and...

Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships

Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships
by Brian Baldo (Author), Nghia H Pham (Author)


The variety of chemically diverse pharmacological agents administered to patients is large and continues to expand and with every new drug released, there is always potential for adverse reactions, some of them allergic. With its roots in immunology and pharmacology, the science of drug allergy is becoming better understood and applied as its importance is increasingly recognized throughout the many branches of medicine.   Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships sheds new light on this field. Comprehensive in design, this authoritative title identifies the most important culprit drugs implicated in immediate and delayed drug hypersensitivities and offers up-to-date information on classifications, diagnoses, underlying mechanisms and...

© 2016 BrightSurf.com